Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 31Squamous Cell Carcinoma of Head and Neck 21Carcinoma, Non-Small-Cell Lung 20Neoplasms 18Breast Neoplasms 18Glioblastoma 17Esophageal Squamous Cell Carcinoma 16Rectal Neoplasms 15Lung Neoplasms 15Esophageal Neoplasms 15Head and Neck Neoplasms 12Uterine Cervical Neoplasms 11Neoplasm Metastasis 10Glioma 10Nasopharyngeal Carcinoma 8Stomach Neoplasms 7Radiation Injuries 7Oropharyngeal Neoplasms 7Brain Neoplasms 7Hyperthermia 6Carcinoma, Hepatocellular 6Astrocytoma 6Urinary Bladder Neoplasms 5Small Cell Lung Carcinoma 5Sarcoma 5Oligodendroglioma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 4

Interventions

Radiosurgery 2neratinib 1lutetium Lu 177 dotatate 1capivasertib 1avasopasem manganese 1Valproic Acid 1Taxes 1Sevoflurane 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Image-Guided 1Radiotherapy 1Propofol 1Nivolumab 1Multiparametric Magnetic Resonance Imaging 1Gemcitabine 1Everolimus 1Etoposide 1Cystectomy 1Clinical Trials, Phase II as Topic 1Clinical Trials, Phase I as Topic 1Cisplatin 1Carboplatin 1Blood Specimen Collection 1Biopsy 1Anesthesia, Inhalation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Disease Progression × Radiotherapy × Clear all
NCT07008716 2025-06-06

Omitting CTV for Primary Tumor in LS-SCLC

Sun Yat-sen University

Phase 3 Recruiting
852 enrolled

Radiation Injuries, Disease Progression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡